EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
|
EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today. Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using their electronic health card and their mobile phone. The eHealth-CardLink solution is expected to be available in Redcare Pharmacy´s German Shop Apotheke app by early May.
Contact: rikutis consulting Thomas Schnorrenberg Cel: +49 151 46 53 13 17 E-Mail: [email protected] End of Inside Information
23-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1887349 |
| End of Announcement | EQS News Service |
|
|
1887349 23-Apr-2024 CET/CEST
Shop Apotheke Europe NV Aktie
Die Community zeigt eindeutige Unterstützung für Shop Apotheke Europe NV mit mehreren Buy-Einschätzungen und keinen Sell-Einschätzungen.
Das Community-Kursziel von 154 € für Shop Apotheke Europe NV deutet auf ein leicht positives Wachstumspotenzial gegenüber 128.6 € hin.
